Logo image of XMPT

VANECK CEF MUNI INCOME ETF (XMPT) Stock Price, Quote, News and Overview

NYSEARCA:XMPT - NYSE Arca - US92189F4607 - ETF - Currency: USD

20.66  -0.12 (-0.58%)

Fundamental Rating

6

XMPT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 80 industry peers in the Automobile Components industry. XMPT scores excellent on profitability, but there are some minor concerns on its financial health. XMPT scores decently on growth, while it is valued quite cheap. This could make an interesting combination. XMPT also has an excellent dividend rating. These ratings could make XMPT a good candidate for value and dividend investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year XMPT was profitable.
XMPT had a positive operating cash flow in the past year.
XMPT had positive earnings in each of the past 5 years.
XMPT had a positive operating cash flow in each of the past 5 years.
XMPT Yearly Net Income VS EBIT VS OCF VS FCFXMPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

1.2 Ratios

With a decent Return On Assets value of 5.04%, XMPT is doing good in the industry, outperforming 77.50% of the companies in the same industry.
The Return On Equity of XMPT (10.12%) is better than 76.25% of its industry peers.
XMPT has a better Return On Invested Capital (8.73%) than 76.25% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for XMPT is in line with the industry average of 9.12%.
Industry RankSector Rank
ROA 5.04%
ROE 10.12%
ROIC 8.73%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
XMPT Yearly ROA, ROE, ROICXMPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a decent Profit Margin value of 6.93%, XMPT is doing good in the industry, outperforming 80.00% of the companies in the same industry.
In the last couple of years the Profit Margin of XMPT has remained more or less at the same level.
XMPT has a better Operating Margin (11.72%) than 82.50% of its industry peers.
In the last couple of years the Operating Margin of XMPT has remained more or less at the same level.
XMPT has a Gross Margin of 28.49%. This is in the better half of the industry: XMPT outperforms 75.00% of its industry peers.
XMPT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.72%
PM (TTM) 6.93%
GM 28.49%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
XMPT Yearly Profit, Operating, Gross MarginsXMPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

XMPT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, XMPT has less shares outstanding
The number of shares outstanding for XMPT has been reduced compared to 5 years ago.
XMPT has a worse debt/assets ratio than last year.
XMPT Yearly Shares OutstandingXMPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
XMPT Yearly Total Debt VS Total AssetsXMPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

XMPT has an Altman-Z score of 2.23. This is not the best score and indicates that XMPT is in the grey zone with still only limited risk for bankruptcy at the moment.
XMPT has a Altman-Z score of 2.23. This is in the lower half of the industry: XMPT underperforms 62.50% of its industry peers.
XMPT has a debt to FCF ratio of 3.42. This is a good value and a sign of high solvency as XMPT would need 3.42 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.42, XMPT is in the better half of the industry, outperforming 78.75% of the companies in the same industry.
A Debt/Equity ratio of 0.31 indicates that XMPT is not too dependend on debt financing.
XMPT has a Debt to Equity ratio of 0.31. This is in the better half of the industry: XMPT outperforms 72.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.42
Altman-Z 2.23
ROIC/WACC1.38
WACC6.31%
XMPT Yearly LT Debt VS Equity VS FCFXMPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

XMPT has a Current Ratio of 1.76. This is a normal value and indicates that XMPT is financially healthy and should not expect problems in meeting its short term obligations.
XMPT has a Current ratio of 1.76. This is comparable to the rest of the industry: XMPT outperforms 57.50% of its industry peers.
A Quick Ratio of 1.11 indicates that XMPT should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.11, XMPT is in line with its industry, outperforming 57.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.11
XMPT Yearly Current Assets VS Current LiabilitesXMPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

XMPT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.42%.
XMPT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.64% yearly.
Looking at the last year, XMPT shows a decrease in Revenue. The Revenue has decreased by -4.06% in the last year.
The Revenue has been growing slightly by 2.41% on average over the past years.
EPS 1Y (TTM)-5.42%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-5.56%
Revenue 1Y (TTM)-4.06%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.87%

3.2 Future

The Earnings Per Share is expected to grow by 17.51% on average over the next years. This is quite good.
XMPT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.24% yearly.
EPS Next Y35.36%
EPS Next 2Y23.07%
EPS Next 3Y17.51%
EPS Next 5YN/A
Revenue Next Year0.83%
Revenue Next 2Y2%
Revenue Next 3Y2.43%
Revenue Next 5Y3.24%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XMPT Yearly Revenue VS EstimatesXMPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
XMPT Yearly EPS VS EstimatesXMPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

9

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 6.82 indicates a rather cheap valuation of XMPT.
Based on the Price/Earnings ratio, XMPT is valued cheaper than 88.75% of the companies in the same industry.
When comparing the Price/Earnings ratio of XMPT to the average of the S&P500 Index (27.48), we can say XMPT is valued rather cheaply.
The Price/Forward Earnings ratio is 5.03, which indicates a rather cheap valuation of XMPT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of XMPT indicates a rather cheap valuation: XMPT is cheaper than 90.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of XMPT to the average of the S&P500 Index (36.52), we can say XMPT is valued rather cheaply.
Industry RankSector Rank
PE 6.82
Fwd PE 5.03
XMPT Price Earnings VS Forward Price EarningsXMPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

88.75% of the companies in the same industry are more expensive than XMPT, based on the Enterprise Value to EBITDA ratio.
86.25% of the companies in the same industry are more expensive than XMPT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.85
EV/EBITDA 2.89
XMPT Per share dataXMPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
XMPT has a very decent profitability rating, which may justify a higher PE ratio.
XMPT's earnings are expected to grow with 17.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.19
PEG (5Y)4.15
EPS Next 2Y23.07%
EPS Next 3Y17.51%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.23%, XMPT is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.19, XMPT has a dividend in line with its industry peers.
XMPT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 4.23%

5.2 History

The dividend of XMPT is nicely growing with an annual growth rate of 7.84%!
XMPT has been paying a dividend for at least 10 years, so it has a reliable track record.
XMPT has decreased its dividend recently.
Dividend Growth(5Y)7.84%
Div Incr Years1
Div Non Decr Years1
XMPT Yearly Dividends per shareXMPT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

XMPT pays out 51.01% of its income as dividend. This is a bit on the high side, but may be sustainable.
XMPT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP51.01%
EPS Next 2Y23.07%
EPS Next 3Y17.51%
XMPT Yearly Income VS Free CF VS DividendXMPT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
XMPT Dividend Payout.XMPT Dividend Payout, showing the Payout Ratio.XMPT Dividend Payout.PayoutRetained Earnings

VANECK CEF MUNI INCOME ETF

NYSEARCA:XMPT (7/17/2025, 8:04:00 PM)

20.66

-0.12 (-0.58%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)04-24 2025-04-24
Earnings (Next)07-24 2025-07-24
Inst Owners39.91%
Inst Owner Change0%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap14.58B
Analysts80
Price Target23.53 (13.89%)
Short Float %0.01%
Short Ratio1.02
Dividend
Industry RankSector Rank
Dividend Yield 4.23%
Yearly Dividend1.58
Dividend Growth(5Y)7.84%
DP51.01%
Div Incr Years1
Div Non Decr Years1
Ex-Date07-01 2025-07-01 (0.1033)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8.13%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.7%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.5%
Valuation
Industry RankSector Rank
PE 6.82
Fwd PE 5.03
P/S 0.46
P/FCF 5.85
P/OCF 2.9
P/B 0.68
P/tB 0.92
EV/EBITDA 2.89
EPS(TTM)3.03
EY14.67%
EPS(NY)4.11
Fwd EY19.88%
FCF(TTM)3.53
FCFY17.11%
OCF(TTM)7.11
OCFY34.43%
SpS44.61
BVpS30.56
TBVpS22.44
PEG (NY)0.19
PEG (5Y)4.15
Profitability
Industry RankSector Rank
ROA 5.04%
ROE 10.12%
ROCE 11.13%
ROIC 8.73%
ROICexc 10.35%
ROICexgc 13.02%
OM 11.72%
PM (TTM) 6.93%
GM 28.49%
FCFM 7.92%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
ROICexc(3y)10.37%
ROICexc(5y)9.81%
ROICexgc(3y)12.78%
ROICexgc(5y)12.13%
ROCE(3y)11.87%
ROCE(5y)10.97%
ROICexcg growth 3Y-1.65%
ROICexcg growth 5Y0.27%
ROICexc growth 3Y-2.16%
ROICexc growth 5Y0.21%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
F-Score5
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.42
Debt/EBITDA 1.12
Cap/Depr 110.04%
Cap/Sales 8.02%
Interest Coverage 12.7
Cash Conversion 83.87%
Profit Quality 114.33%
Current Ratio 1.76
Quick Ratio 1.11
Altman-Z 2.23
F-Score5
WACC6.31%
ROIC/WACC1.38
Cap/Depr(3y)113.8%
Cap/Depr(5y)101.88%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.42%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-5.56%
EPS Next Y35.36%
EPS Next 2Y23.07%
EPS Next 3Y17.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.06%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.87%
Revenue Next Year0.83%
Revenue Next 2Y2%
Revenue Next 3Y2.43%
Revenue Next 5Y3.24%
EBIT growth 1Y-7.52%
EBIT growth 3Y1.98%
EBIT growth 5Y1.14%
EBIT Next Year66.93%
EBIT Next 3Y23.28%
EBIT Next 5Y17.83%
FCF growth 1Y-29.4%
FCF growth 3Y21.5%
FCF growth 5Y7.22%
OCF growth 1Y-17.99%
OCF growth 3Y14.27%
OCF growth 5Y5.48%